Kamel-Reid S - Search Results

1

Validation of KRAS testing for anti-EGFR therapeutic decisions for patients with metastatic colorectal carcinoma.

Kamel-Reid S, Zhang T, Persons DL, Nikiforova MN, Halling KC; Molecular Oncology Resource Committee of the College of American Pathologists. Kamel-Reid S, et al. Arch Pathol Lab Med. 2012 Jan;136(1):26-32. doi: 10.5858/arpa.2011-0220-OA. Arch Pathol Lab Med. 2012. PMID: 22208484 Free article.

2

Design and analytic validation of BCR-ABL1 quantitative reverse transcription polymerase chain reaction assay for monitoring minimal residual disease.

Jennings LJ, Smith FA, Halling KC, Persons DL, Kamel-Reid S; Molecular Oncology Resource Committee of the College of American Pathologists. Jennings LJ, et al. Arch Pathol Lab Med. 2012 Jan;136(1):33-40. doi: 10.5858/arpa.2011-0136-OA. Arch Pathol Lab Med. 2012. PMID: 22208485 Free article.

3

Integration of Technical, Bioinformatic, and Variant Assessment Approaches in the Validation of a Targeted Next-Generation Sequencing Panel for Myeloid Malignancies.

Thomas M, Sukhai MA, Zhang T, Dolatshahi R, Harbi D, Garg S, Misyura M, Pugh T, Stockley TL, Kamel-Reid S. Thomas M, et al. Arch Pathol Lab Med. 2017 Jun;141(6):759-775. doi: 10.5858/arpa.2016-0547-RA. Epub 2017 Mar 9. Arch Pathol Lab Med. 2017. PMID: 28557600 Free article.

4

Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21.

Zhu CQ, da Cunha Santos G, Ding K, Sakurada A, Cutz JC, Liu N, Zhang T, Marrano P, Whitehead M, Squire JA, Kamel-Reid S, Seymour L, Shepherd FA, Tsao MS; National Cancer Institute of Canada Clinical Trials Group Study BR.21. Zhu CQ, et al. J Clin Oncol. 2008 Sep 10;26(26):4268-75. doi: 10.1200/JCO.2007.14.8924. Epub 2008 Jul 14. J Clin Oncol. 2008. PMID: 18626007

5

Comparison of Next-Generation Sequencing Panels and Platforms for Detection and Verification of Somatic Tumor Variants for Clinical Diagnostics.

Misyura M, Zhang T, Sukhai MA, Thomas M, Garg S, Kamel-Reid S, Stockley TL. Misyura M, et al. J Mol Diagn. 2016 Nov;18(6):842-850. doi: 10.1016/j.jmoldx.2016.06.004. J Mol Diagn. 2016. PMID: 27770852 Free article.

6

Guidelines for Validation of Next-Generation Sequencing-Based Oncology Panels: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists.

Jennings LJ, Arcila ME, Corless C, Kamel-Reid S, Lubin IM, Pfeifer J, Temple-Smolkin RL, Voelkerding KV, Nikiforova MN. Jennings LJ, et al. J Mol Diagn. 2017 May;19(3):341-365. doi: 10.1016/j.jmoldx.2017.01.011. Epub 2017 Mar 21. J Mol Diagn. 2017. PMID: 28341590 Free PMC article. Review.

7

Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens.

Malapelle U, Mayo-de-Las-Casas C, Molina-Vila MA, Rosell R, Savic S, Bihl M, Bubendorf L, Salto-Tellez M, de Biase D, Tallini G, Hwang DH, Sholl LM, Luthra R, Weynand B, Vander Borght S, Missiaglia E, Bongiovanni M, Stieber D, Vielh P, Schmitt F, Rappa A, Barberis M, Pepe F, Pisapia P, Serra N, Vigliar E, Bellevicine C, Fassan M, Rugge M, de Andrea CE, Lozano MD, Basolo F, Fontanini G, Nikiforov YE, Kamel-Reid S, da Cunha Santos G, Nikiforova MN, Roy-Chowdhuri S, Troncone G; Molecular Cytopathology Meeting Group. Malapelle U, et al. Cancer Cytopathol. 2017 Aug;125(8):615-626. doi: 10.1002/cncy.21868. Epub 2017 May 5. Cancer Cytopathol. 2017. PMID: 28475299 Free article.

8

Improving validation methods for molecular diagnostics: application of Bland-Altman, Deming and simple linear regression analyses in assay comparison and evaluation for next-generation sequencing.

Misyura M, Sukhai MA, Kulasignam V, Zhang T, Kamel-Reid S, Stockley TL. Misyura M, et al. J Clin Pathol. 2018 Feb;71(2):117-124. doi: 10.1136/jclinpath-2017-204520. Epub 2017 Jul 26. J Clin Pathol. 2018. PMID: 28747393 Free PMC article.

9

Performance Comparison of Different Analytic Methods in Proficiency Testing for Mutations in the BRAF, EGFR, and KRAS Genes: A Study of the College of American Pathologists Molecular Oncology Committee.

Moncur JT, Bartley AN, Bridge JA, Kamel-Reid S, Lazar AJ, Lindeman NI, Long TA, Merker JD, Rai AJ, Rimm DL, Rothberg PG, Vasalos P, Kim AS. Moncur JT, et al. Arch Pathol Lab Med. 2019 Oct;143(10):1203-1211. doi: 10.5858/arpa.2018-0396-CP. Epub 2019 Apr 10. Arch Pathol Lab Med. 2019. PMID: 30969158 Free article.

10

The association between EGFR variant III, HPV, p16, c-MET, EGFR gene copy number and response to EGFR inhibitors in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

Chau NG, Perez-Ordonez B, Zhang K, Pham NA, Ho J, Zhang T, Ludkovski O, Wang L, Chen EX, Tsao MS, Kamel-Reid S, Siu LL. Chau NG, et al. Head Neck Oncol. 2011 Feb 27;3:11. doi: 10.1186/1758-3284-3-11. Head Neck Oncol. 2011. PMID: 21352589 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

252 results

Search Page

Filters